Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 58.31% | 88.68% | 21.32% | -5.29% | 20.09% |
| Total Depreciation and Amortization | -61.19% | -60.87% | 69.23% | 2,249.02% | 3,008.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.86% | -96.38% | -93.43% | -4.45% | -115.98% |
| Change in Net Operating Assets | 116.83% | 99.23% | 46.19% | 280.61% | -826.29% |
| Cash from Operations | 85.58% | 90.88% | 10.32% | 3.98% | -99.00% |
| Capital Expenditure | 80.91% | 100.00% | 99.42% | -770.45% | -1,571.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 108.62% | 90.25% | 110.10% | 136.49% |
| Cash from Investing | -117.40% | 103.42% | 96.38% | 94.54% | 118.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -574.60% | -25.40% | -125.40% | -328.57% | -384.62% |
| Issuance of Common Stock | -- | -- | -- | -52.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -578.26% | -22.92% | -116.33% | -55.48% | -318.18% |
| Foreign Exchange rate Adjustments | 106.44% | -103.18% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.25% | 94.10% | 42.89% | -102.73% | -72.91% |
